Related Experiment Video
Updated: Dec 3, 2025

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses
Published on: March 8, 2024
[Interdisciplinary COVID board for patients with SARS-CoV-2-triggered hyperferritinemic Inflammation]
P La Rosée1,2, H-C Bremer3, F La Rosée4,5
1Klinik für Innere Medizin II, Hämatologie, Onkologie, Immunologie, Infektiologie und Palliativmedizin, Schwarzwald-Baar-Klinikum, Klinikstr. 11, 78052, Villingen-Schwenningen, Deutschland. paul.larosee@sbk-vs.de.
Severe COVID-19 patients experienced hyperferritinemic inflammation, a sepsis-like condition. A telemedical approach and targeted ruxolitinib treatment reduced inflammation and mortality in high-risk cases.
Area of Science:
- Critical Care Medicine
- Immunology
- Infectious Diseases
Background:
- Severe COVID-19 is characterized by hyperferritinemic inflammation, a rare sepsis-like immune dysregulation.
- This condition resembles macrophage activation syndrome, a severe inflammatory response.
Purpose of the Study:
- To evaluate the effectiveness of a telemedical interdisciplinary case conference for managing severe COVID-19 patients.
- To assess the impact of a standardized treatment algorithm and targeted immune modulation on patient outcomes.
Main Methods:
- Retrospective cohort study analyzing 196 COVID-19 patients.
- Implementation of a standardized treatment algorithm including non-invasive ventilation.
- Utilized a COVID inflammation score (CIS) to identify high-risk patients for off-label ruxolitinib treatment.
Main Results:
- Ruxolitinib treatment in high-risk patients (n=20) suppressed inflammation by 42-60% over 15 days.
- Mortality in ruxolitinib-treated patients was 20%.
- Overall mortality, adjusted for care directives, was 8.7% (17/196).
Conclusions:
- Hyperferritinemic inflammation in severe COVID-19 is linked to macrophage activation syndrome-like sepsis.
- An interdisciplinary teleconference is proposed as a quality tool for ICUs to detect rare sepsis-like syndromes.
More Related Videos
Related Concept Videos
Myocarditis III: Medical Management
Chronic Pancreatitis II: Collaborative Care
Assessment:
Pericarditis III: Medical Management
Endocarditis III: Medical Management
Myocarditis IV: Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

